title: Frontal fibrosing alopecia: a pathology on the rise
abstract: Frontal fibrosing alopecia (FFA) is a scarring alopecia whose incidence is increasing significantly in our country. It is characterized by loss of frontotemporal hairline that mostly affects postmenopausal women, with a negative impact on quality of life. It is associated with early menopause in 14% of cases and hypothyroidism in 15%. With regard to treatment, 5α-reductase inhibitors are the drugs that have shown improvement of the disease in a larger number of cases. We report a new case of FFA in a woman of 77 years successfully treated with finasteride at doses of 2.5mg daily.
authors.affiliation: . adriandeq@gmail.com.
authors.forename: A
authors.initials: A
authors.lastname: De Quintana Sancho
authors.forename: X
authors.initials: X
authors.lastname: Piris-García
authors.forename: J N
authors.initials: JN
authors.lastname: Valle-García
authors.forename: M
authors.initials: M
authors.lastname: Hierro-Cámara
mesh_terms: D058891:5-alpha Reductase Inhibitors / Q000627:therapeutic use; D000368:Aged; D000505:Alopecia / Q000188:drug therapy / Q000453:epidemiology; D005260:Female; D018120:Finasteride / Q000627:therapeutic use; D006801:Humans; D012074:Remission Induction
chemical_list: D058891:5-alpha Reductase Inhibitors; D018120:Finasteride